197 related articles for article (PubMed ID: 21541196)
1. Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.
Fan C; Georgiou KR; King TJ; Xian CJ
J Biomed Biotechnol; 2011; 2011():903097. PubMed ID: 21541196
[TBL] [Abstract][Full Text] [Related]
2. Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells.
Xian CJ; Cool JC; Scherer MA; Fan C; Foster BK
J Cell Physiol; 2008 Mar; 214(3):777-85. PubMed ID: 17786974
[TBL] [Abstract][Full Text] [Related]
3. Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate.
Fan CM; Foster BK; Hui SK; Xian CJ
PLoS One; 2012; 7(10):e46915. PubMed ID: 23071661
[TBL] [Abstract][Full Text] [Related]
4. Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss.
Lee AM; Shandala T; Soo PP; Su YW; King TJ; Chen KM; Howe PR; Xian CJ
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28282956
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
6. Fish oil in comparison to folinic acid for protection against adverse effects of methotrexate chemotherapy on bone.
Raghu Nadhanan R; Fan CM; Su YW; Howe PR; Xian CJ
J Orthop Res; 2014 Apr; 32(4):587-96. PubMed ID: 24346859
[TBL] [Abstract][Full Text] [Related]
7. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis.
Fan C; Foster BK; Wallace WH; Xian CJ
Curr Mol Med; 2011 Mar; 11(2):140-51. PubMed ID: 21342129
[TBL] [Abstract][Full Text] [Related]
8. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
[TBL] [Abstract][Full Text] [Related]
9. Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects.
Xian CJ; Cool JC; Scherer MA; Macsai CE; Fan C; Covino M; Foster BK
Bone; 2007 Nov; 41(5):842-50. PubMed ID: 17884747
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.
Georgiou KR; Scherer MA; Fan CM; Cool JC; King TJ; Foster BK; Xian CJ
J Cell Physiol; 2012 Mar; 227(3):909-18. PubMed ID: 21503894
[TBL] [Abstract][Full Text] [Related]
11. Notch2 Blockade Mitigates Methotrexate Chemotherapy-Induced Bone Loss and Marrow Adiposity.
Peymanfar Y; Su YW; Xian CJ
Cells; 2022 May; 11(9):. PubMed ID: 35563828
[TBL] [Abstract][Full Text] [Related]
12. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
13. Effect of methotrexate and folinic acid on skeletal growth in mice.
Iqbal MP; Ahmed M; Umer M; Mehboobali N; Qureshi AA
Acta Paediatr; 2003 Dec; 92(12):1438-44. PubMed ID: 14971796
[TBL] [Abstract][Full Text] [Related]
14. Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.
King TJ; Shandala T; Lee AM; Foster BK; Chen KM; Howe PR; Xian CJ
Int J Mol Sci; 2015 Aug; 16(8):18293-311. PubMed ID: 26258775
[TBL] [Abstract][Full Text] [Related]
15. Childhood cancer chemotherapy-induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals.
Su YW; Chen KM; Hassanshahi M; Tang Q; Howe PR; Xian CJ
Ann N Y Acad Sci; 2017 Sep; 1403(1):109-117. PubMed ID: 28662275
[TBL] [Abstract][Full Text] [Related]
16. Roles of apoptotic chondrocyte-derived CXCL12 in the enhanced chondroclast recruitment following methotrexate and/or dexamethasone treatment.
Su YW; Fan J; Fan CM; Peymanfar Y; Zhang YL; Xian CJ
J Cell Physiol; 2021 Aug; 236(8):5966-5979. PubMed ID: 33438203
[TBL] [Abstract][Full Text] [Related]
17. Effects of chemotherapy on bone metabolism and skeletal growth.
Siebler T; Shalet SM; Robson H
Horm Res; 2002; 58 Suppl 1():80-5. PubMed ID: 12373019
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of the CXCL12/CXCR4 axis in methotrexate chemotherapy-induced damage and recovery of the bone marrow microenvironment.
Georgiou KR; Scherer MA; King TJ; Foster BK; Xian CJ
Int J Exp Pathol; 2012 Apr; 93(2):104-14. PubMed ID: 22220905
[TBL] [Abstract][Full Text] [Related]
19. β-Catenin signaling is important for osteogenesis and hematopoiesis recovery following methotrexate chemotherapy in rats.
Fan J; Su YW; Hassanshahi M; Fan CM; Peymanfar Y; Piergentili A; Del Bello F; Quaglia W; Xian CJ
J Cell Physiol; 2021 May; 236(5):3740-3751. PubMed ID: 33078406
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate-induced bone marrow adiposity is mitigated by folinic acid supplementation through the regulation of Wnt/β-catenin signalling.
Georgiou KR; Nadhanan RR; Fan CM; Xian CJ
J Cell Physiol; 2015 Mar; 230(3):648-56. PubMed ID: 25187349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]